Thermo Fisher Scientific (TMO)
(Delayed Data from NYSE)
$596.92 USD
+3.13 (0.53%)
Updated Oct 11, 2024 04:00 PM ET
After-Market: $596.52 -0.40 (-0.07%) 7:58 PM ET
3-Hold of 5 3
C Value D Growth D Momentum D VGM
Thermo Fisher Scientific (TMO) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Upside to Average Price Target |
---|---|---|---|
$656.68 | $767.00 | $565.00 | 10.59% |
Price Target
Based on short-term price targets offered by 22 analysts, the average price target for Thermo Fisher Scientific comes to $656.68. The forecasts range from a low of $565.00 to a high of $767.00. The average price target represents an increase of 10.59% from the last closing price of $593.79.
Analyst Price Targets (22)
Broker Rating
Thermo Fisher Scientific currently has an average brokerage recommendation (ABR) of 1.44 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by 24 brokerage firms. The current ABR compares to an ABR of 1.50 a month ago based on 21 recommendations.
Of the 24 recommendations deriving the current ABR, 17 are Strong Buy and three are Buy. Strong Buy and Buy respectively account for 70.83% and 12.5% of all recommendations. A month ago, Strong Buy made up 66.67%, while Buy represented 14.29%.
Broker Rating Breakdown
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 17 | 17 | 14 | 13 | 13 |
Buy | 3 | 3 | 3 | 3 | 3 |
Hold | 4 | 4 | 4 | 4 | 4 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 |
ABR | 1.44 | 1.44 | 1.50 | 1.52 | 1.52 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
10/1/2024 | Evercore Partners | Vijay Kumar | Strong Buy | Strong Buy |
10/1/2024 | Stephens | Jacob Johnson | Not Available | Strong Buy |
9/20/2024 | Argus Research Corp. | David A Toung | Strong Buy | Strong Buy |
9/20/2024 | Not Identified | Not Identified | Moderate Buy | Moderate Buy |
9/19/2024 | Not Identified | Not Identified | Hold | Hold |
9/18/2024 | Not Identified | Not Identified | Strong Buy | Strong Buy |
9/16/2024 | UBS | Dan Leonard | Not Available | Strong Buy |
8/28/2024 | KeyBanc Capital Markets | Paul Knight | Hold | Hold |
8/27/2024 | Wells Fargo Securities | Brandon Couillard | Not Available | Strong Buy |
8/6/2024 | Not Identified | Not Identified | Strong Buy | Strong Buy |
7/25/2024 | Cowen & Co. | Daniel Brennan | Strong Buy | Strong Buy |
7/25/2024 | Goldman Sachs | Matthew Sykes | Strong Buy | Strong Buy |
7/25/2024 | Robert W. Baird & Co. | Catherine W Schulte | Strong Buy | Strong Buy |
7/24/2024 | SVB Securities | Puneet Souda | Strong Buy | Strong Buy |
7/24/2024 | Not Identified | Not Identified | Strong Buy | Strong Buy |
7/24/2024 | Not Identified | Not Identified | Strong Buy | Strong Buy |
7/16/2024 | Raymond James | Andrew Cooper | Moderate Buy | Moderate Buy |
6/3/2024 | Not Identified | Not Identified | Not Available | Strong Buy |
4/25/2024 | Not Identified | Not Identified | Hold | Hold |
3/18/2024 | Not Identified | Not Identified | Strong Buy | Hold |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 1.44 |
ABR (Last week) | 1.44 |
# of Recs in ABR | 24 |
Average Target Price | $656.68 |
LT Growth Rate | 7.20% |
Industry | Medical - Instruments |
Industry Rank by ABR | 96 of 252 |
Current Quarter EPS Est: | 5.25 |
TMO FAQs
Thermo Fisher Scientific Inc. (TMO) currently has an average brokerage recommendation (ABR) of 1.44 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by 24 brokerage firms.
The average price target for Thermo Fisher Scientific Inc. (TMO) is $656.68. The current on short-term price targets is based on 11 reports.
The forecasts for Thermo Fisher Scientific Inc. (TMO) range from a low of $565 to a high of $767. The average price target represents a increase of $10.01 from the last closing price of $596.92.
The current UPSIDE for Thermo Fisher Scientific Inc. (TMO) is 10.01%
Based on short-term price targets offered by 22 analysts, the average price target for Thermo Fisher Scientific comes to $656.68. The forecasts range from a low of $565.00 to a high of $767.00. The average price target represents an increase of 10.59% from the last closing price of $593.79.